bayer ag-reg (BAYZF) Key Developments
Bayer AG to Early Redeem EUR 1.3 Billion Bond Issued in 2005
Apr 15 15
Bayer AG plans to early redeem a EUR 1.3 billion bond. The first opportunity to repay the subordinated bond with a 5% coupon and a 100-year maturity issued in 2005 (ISIN XS0225369403) arises on July 29, 2015. The company has decided to utilize this repayment right. The company will arrange for publication of a formal investor notification in the newspaper Luxemburger Wort or through the clearing system in June 2015 in accordance with the bond conditions.
Bayer AG Proposes Dividend for the Year 2014
Mar 29 15
The Board of Management and the Supervisory Board of Bayer AG propose that the entire distributable profit of EUR 1,860,632,568.00 reported in the annual financial statements for the fiscal year 2014 be used to pay a dividend of EUR 2.25 per share carrying dividend rights, at the AGM to be held on May 27, 2015.
Bayer AG Proposes Amendment to the Articles of Incorporation
Mar 27 15
Bayer AG proposed amendment of the Object of the company (Section 2, Paragraph 1 of the Articles of Incorporation) to the AGM to be held on May 27, 2015.
Bayer To Sell Oral Contraceptive Pill Operation
Mar 23 15
South Korea's anti-trust regulator ordered the local subsidiary of Bayer AG (DB:BAYN) to sell its oral contraceptive pill operation that it acquired when its parent bought Merck & Co., citing conflicts with the country's fair trade rules. The Fair Trade Commission (FTC) said it ordered Bayer Korea Ltd. to dispose of its assets and rights related to all Mercilon tablet business in the country. "The decision was made because Bayer's dominance in a market that is already controlled by imported drugs could be detrimental to the interest of consumers," the FTC said, adding that the measure could preempt any moves by Bayer to hike up prices for its drugs.
Bayer Considering Multiple Strategic Alternatives For Home And Garden Consumer Products
Mar 20 15
Bayer AG (DB:BAYN) is considering multiple strategic alternatives for home and garden consumer products business. Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers. "A number of strategic alternatives are under consideration," a spokesman for the diversified drugs and pesticides maker said on March 20, 2015. People familiar with the matter told Reuters that Bayer was preparing to sell the business and was gauging the interest of prospective buyers, which could be private equity or industry players. The business generated €220 million euros in annual sales in 2014.